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Abstract
Introduction: There is an urgent need to validate telephone versions of widely used
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general cognitive measures, such as the Montreal Cognitive Assessment (T-MoCA), for
remote assessments.
Methods: In the Einstein Aging Study, a diverse community cohort (n = 428; mean
age = 78.1; 66% female; 54% non-White), equivalence testing was used to examine
concordance between the T-MoCA and the corresponding in-person MoCA assess-

4

Department of Psychology, Fordham
University, Bronx, New York, USA

ment. Receiver operating characteristic analyses examined the diagnostic ability to dis-
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criminate between mild cognitive impairment and normal cognition. Conversion meth-
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Results: Education, race/ethnicity, gender, age, self-reported cognitive concerns, and
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ods from T-MoCA to the MoCA are presented.
telephone administration difficulties were associated with both modes of administration; however, when examining the difference between modalities, these factors were
not significant. Sensitivity and specificity for the T-MoCA (using Youden’s index opti-
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mal cut) were 72% and 59%, respectively.
Discussion: The T-MoCA demonstrated sufficient psychometric properties to be useful for screening of MCI, especially when clinic visits are not feasible.
KEYWORDS

cognitive screening scales, equivalence testing, mild cognitive impairment, Montreal Cognitive
Assessment, neuropsychology, remote assessment, telephone screening

1

INTRODUCTION

age sensitivity 94%, average specificity 76%) from those who are
cognitively unimpaired.5 The MoCA-30 has been translated and

The number of individuals at risk for cognitive impairment is growing

validated for use in various languages, cultures, and administration

rapidly as the population ages,1,2

modalities.5 Compared to another commonly used cognitive screen,

yet dementia often goes undiagnosed
Sensitive screening measures

the Mini-Mental State Examination (MMSE),6 the MoCA has been

are essential to identify individuals at risk for future cognitive decline.

consistently recognized as more sensitive to mild cognitive changes

The Montreal Cognitive Assessment (MoCA-30)4 is a widely used,

with similar levels of specificity.7–15 The MoCA-30 more compre-

extensively studied, paper-and-pencil screening tool for distinguishing

hensively evaluates a broad range of cognitive domains and more

individuals with mild cognitive impairment (MCI; average sensitivity

closely aligns with neuropsychological test scores than does the

85%, average specificity 76%) and Alzheimer’s disease (AD; aver-

MMSE.16

or diagnosed in late disease

stages.3

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2021 The Authors. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer’s Association
Alzheimer’s Dement. 2021;13:e12144.
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Given the rapidly expanding older adult population,1,2 remotely
administered, validated screening tools for cognitive impairment
are increasingly necessary and have far-reaching applications,
including use with rural-living individuals, for ease of follow-up and
disease monitoring, and for continuity of care. Telephone17–19 and
videoconferencing-based20–24 versions of the MoCA-30 have been
developed, but their performance has not been assessed in diverse
samples at increased risk for cognitive impairment based on age,
race, and socioeconomic status. In addition, the broad applicability

HIGHLIGHTS
∙ The telephone Montreal Cognitive Assessment (T-MoCA)
was validated in a diverse, community-residing cohort.
∙ The T-MoCA differentiates mild cognitive impairment
from cognitively normal older adults.
∙ Two conversion methods are presented for estimating
MoCA-30 scores based on the T-MoCA.

of videoconferencing is questionable because it relies on expensive
technological resources (including high-speed internet and access to
a computer, smartphone, or tablet and a printer) and technological
proficiency. This greatly reduces the applicability of this method

RESEARCH IN CONTEXT

for detecting dementia risk in under-resourced individuals, or for

1. Systematic review: There has been a dearth of publi-

evaluating older adults who do not have access to technology or who

cations on telephone-administered instruments used

are already cognitively impaired. Telephone-based screening has the

to screen for cognitive impairment, particularly in

potential to address many of these limitations. However, there is a

community-based rather than specialty clinic-based

need to establish the validity of telephone screens, especially in the

settings. The authors carried out an extensive PubMed

age of the COVID-19 pandemic, when clinicians and researchers alike

search for literature on approaches to telephone cogni-

are turning to remotely administered measures.25–27

tive testing in older adults.

The telephone MoCA (T-MoCA) generates a total score with a max-

2. Interpretation: There was a strong concordance between

imum of 22 points, eliminating the MoCA-30 items that require visual

two modified versions of the standard MoCA-30, eg, the

stimuli or the use of paper and pencil. The T-MoCA was originally val-

telephone MoCA (T-MoCA) and an in-person subset of

idated by Pendlebury et al.17 in a population of patients who experi-

the MoCA (MoCA-22). Results indicated statistical equiv-

enced acute vascular events. In general, the T-MoCA does not present

alence between the modified versions and that the T-

the same barriers to access inherent to videoconferencing, as indi-

MoCA could be used to discriminate between mild cog-

viduals can participate via landline or cellphone, without requiring

nitive impairment and those who are cognitively normal.

more advanced technological equipment or proficiency. The T-MoCA

Conversion scores from the T-MoCA to the MoCA-30 are

exhibits adequate sensitivity and specificity for MCI with area under

presented.

the receiver operating characteristic curve (ROC) ranging from 0.73 to

3. Future directions: While results indicate that the T-

0.94 in special samples such as in community-dwelling patients after

MoCA is valid as a cognitive screen when in-clinic

transient ischemic attack (TIA), stroke,17,18 or in patients with atrial

assessment is not feasible, future research should use a

fibrillation.19 In these samples, the T-MoCA has demonstrated similar

longitudinal design to better evaluate the sensitivity of

sensitivity for identifying MCI as the Telephone Interview for Cogni-

the T-MoCA to cognitive changes.

tive Status (TICS),17,18 which correlates highly with the MMSE.28 The
TICS is the most widely translated and validated telephone screen.29
However, a broader literature has revealed that the TICS may be unreliable for distinguishing MCI from normal cognition.30–32 Given that the

Additionally, the ability to reliably convert between the T-MoCA and

MoCA outperforms the MMSE7 for detecting mild cognitive difficul-

the traditional, in-person MoCA-30 scores has not been established.

ties, the T-MoCA is a promising measure for use in less impaired sam-

Data from the Einstein Aging Study (EAS) provide an ideal oppor-

ples when remote testing is required. To date, very few studies have

tunity for comparing the MoCA and the T-MoCA in a large, sys-

independently validated the T-MoCA,18,19 and no validation studies

tematically recruited, multi-racial, economically diverse sample. The

have been conducted in representative, diverse, community-residing

EAS administered the T-MoCA and the MoCA-30 along with full in-

samples of older adults.

person neuropsychological battery and neurologic assessment used to

Prior research has found that performance on the T-MoCA is

assign clinical diagnosis. This allowed the current study to: (1) exam-

highly influenced by education level,19 although it remains unclear

ine the equivalence of the in-person MoCA (MoCA-30), a shortened,

how other relevant demographic variables impact performance for

in-person version of the MoCA-30 (comparable with the T-MoCA, with

the T-MoCA. This is a notable gap in knowledge, as evidence sug-

visual cues and drawing excluded; MoCA-22), and the T-MoCA; (2)

gests that performance on the in-person MoCA-30 is associated with

explore whether demographic variables impact performance differ-

such factors as age,33,34 race/ethnicity,35,36 literacy,37 educational

ences between these measures; (3) assess the sensitivity and specificity

attainment,33–35,37,38 auditory and visual sensory loss,40 background

of the T-MoCA to detect MCI; and (4) use the equipercentile equating

noise,41 and depression.42 Further, no study has directly examined

method with log-linear smoothing and Poisson regression to establish

the equivalence of the T-MoCA with the original, in-person MoCA-30.

conversion scores from the telephone to the in-person MoCA-30.
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2

cal items. At baseline, version 7.2 45 was administered. Scoring details

METHODS

are shown in Table S1 in supporting information.

2.1

Overview of participants and procedures

The MoCA-22 includes a subset of items from the in-person MoCA30 (version 7.2),45 excluding items that require visual cues or drawing,

Data were drawn from the EAS, a longitudinal study of a community-

with a maximum score of 22 points. The MoCA-22 was derived for com-

residing cohort of older adults who are systematically recruited from

parison to the T-MoCA (Table S1).

Bronx County, NY, a racially and ethnically diverse urban setting with

The T-MoCA is a modified version of the MoCA-30 (version 7.1)45

a population of 1.4 million where 11.8% are seniors.43 Since 2004,

administered by phone,17 with minor modifications to scoring (Table

the EAS has used systematic sampling to recruit participants from

S1). Just as with the MoCA-22, this phone version excludes items that

the New York City Board of Elections registered voter lists of the

require visual stimuli and pencil and paper drawing, with the same max-

Bronx. Individuals selected from the list were mailed introductory let-

imum score (Table S1). At baseline, two alternate versions of the MoCA

ters explaining the study and were then telephoned to complete a brief

were administered: version 7.1 was administered on the telephone and

screening interview to determine preliminary eligibility. Eligibility cri-

the alternate form (version 7.2) was administered in-person.

teria were: age ≥70 years, ambulatory status, Bronx residents, noninstitutionalized, English speaking, visual or auditory impairments that
precluded neuropsychological testing, active psychiatric symptoma-

2.3

Covariates

tology that interfered with the ability to complete assessments, and
absence of prevalent dementia based on the telephone version of the
(MIS).44

Demographic information included self-reported race/ethnicity as

Individuals who met preliminary

defined by the US Census Bureau in 1994, number of years of educa-

eligibility criteria on the telephone were invited to an in-person assess-

tion, gender, and age. The Geriatric Depression Scale (GDS, short form)

ment at the EAS clinical research center to confirm and determine final

was used to screen for depressive symptoms. The GDS ranges from 0 to

eligibility. This assessment included a full neuropsychological evalua-

15 with scores of 6 or above suggestive of clinically significant depres-

tion and clinical neurological exam, which were used to confirm that

sive symptoms.46

Memory Impairment Screen

participants did not meet Diagnostic and Statistical Manual of Men-

As part of the telephone screen, nine questions about self-perceived

tal Disorders, 4th edition (DSM-IV) standard criteria for dementia (see

cognitive changes/difficulties were posed to the participant and a sum-

below). Oral and written informed consent were obtained according to

mary score was derived (potential range 0 to 18, Table S2 in supporting

protocols approved by the local institutional review board.

information). The interview also noted and coded five possible difficul-

EAS participants are followed annually with telephone interviews

ties during the telephone assessment including hearing difficulty, sub-

and in-person clinic assessments to extensively phenotype cognitive

optimal hearing conditions, poor attention/motivation, unauthorized

status and document clinical and cognitive change. The telephone com-

use of external sources, and anxiety about performance. The difficul-

ponent serves two purposes: (1) to screen for study eligibility at enroll-

ties are termed “telephone administration difficulties” and were scored

ment and (2) to provide follow-up information for individuals no longer

as “present” by the phone interviewer if at least one difficulty occurred

willing or able to return to the clinic for in-person assessments. In May

(binary variable; Table S3 in supporting information).

2017, the EAS incorporated the T-MoCA into the telephone assessment and the MoCA-30 into the in-person assessment battery.
The analyses presented are based on the first administration of

2.4

Cognitive classification

the MoCA-30 and T-MoCA for 428 EAS participants. Data included
are for the first time that participants completed the T-MoCA and the

In addition to the MoCA-30, the in-person clinic assessments included

MoCA-30, regardless of whether it was the initial (baseline) or annual

the Uniform Data Set Neuropsychological Battery (UDS),47 additional

follow-up study assessment. Of the 428 individuals, 288 had the

neuropsychological measures (Free and Cued Selective Reminding Test

MoCA-30 and T-MoCA administered at their first (enrollment) study

[FCSRT],48 Wechsler Adult Intelligence Scale, Third Edition [WAIS

assessment while the remaining 140 had previously completed annual

III] Block Design,49 Wechsler Logical Memory I,50 and WAIS III Digit

cognitive assessments before these instruments were added to the

Symbol),49 psychosocial measures, personal and family medical his-

protocol.

tories, demographics, indicators of activities of daily living, and selfreports of cognitive concerns.

2.2

Measures of interest
2.4.1

Dementia

The MoCA-30, included in the in-person cognitive battery, assesses
aspects of memory, executive function, attention, concentration, lan-

A diagnosis of dementia was an exclusion criterion for these analy-

guage, abstract reasoning, and orientation, with a maximum score of

ses. During the initial telephone screen, the MIS telephone version

30. Two alternate forms of the MoCA-30 are available to decrease the

was used to screen for severe cognitive impairment. Among those who

likelihood of practice effects due to repeated administration of identi-

passed the initial eligibility screen and who attended the in-person
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clinic visit, dementia diagnosis was based on DSM-IV standardized clincriteria,51

22) between them, controlling for demographic factors (age, gender,

which required impairment in memory and one other

education, and race/ethnicity), depressive symptoms, cognitive con-

cognitive domain with evidence of functional decline. Diagnoses were

cerns, and telephone administration difficulties. To determine whether

assigned annually, at consensus case conferences, where results of

the T-MoCA and MoCA-22 were equivalent, we conducted formal

ical

the neuropsychological and neurological examinations were reviewed

equivalence paired t-tests. Using narrow equivalence bounds of −0.75

along with relevant functional, social, and informant histories. Clinical

and 0.75 points on raw scores, we tested the equivalence between T-

judgment of cognitive decline, particularly with respect to pre-morbid

MoCA and MoCA-22 using the two one-sided tests (TOST).54 Equiv-

and baseline levels of cognition, age, and education were routinely

alence testing was first introduced in pharmacokinetics to show that

taken into account, both in making consensus diagnoses and in formal

a generic drug has a profile equivalent to an existing drug.55,56 Sub-

statistical analyses.

sequently recommended in many research areas,57 this approach was
recently applied in the evaluation of different versions of cognitive
tests.58 The T-MoCA and MoCA-22 would be deemed equivalent if

2.4.2
Mild cognitive impairment (MCI) and normal
cognition (NC)

their difference lies within equivalence bounds defined as −0.75 and
0.75 points on the 22-point scale, which corresponds to Cohen’s d
effect size of 0.3.57,59 The Bland–Altman plot,60 a plot of the difference

Participants who were not diagnosed with dementia were classified as

against the mean of the data pairs for each participant, was also pro-

having MCI or being cognitively normal based on the Jak/Bondi actuar-

vided to visualize the agreement between T-MOCA and MOCA-22.

ial criteria.52 Specifically, 10 neuropsychological instruments that are

ROC analyses were used to evaluate the diagnostic ability of

part of the EAS neuropsychological battery (modified UDS) measuring

T-MoCA, MoCA-22, and MoCA-30 for identifying prevalent MCI.

five cognitive domains were considered for this classification including:

Diagnosis of MCI was assigned without knowledge of the MoCA-30

(1) Memory: Free recall from the Free and Cued Selective Reminding

or T-MoCA performance. Area under the curve (AUC) as a measure

Test, Benson Complex Figure (Delayed); (2) Executive Function: Trail

of diagnostic accuracy was reported and compared.61 Youden’s index,

Making Test Part B (limit time 300 seconds), Phonemic Verbal Fluency

the sum of sensitivity and specificity minus one, was used to select the

(Letters F, and L for 1 minute each); (3) Attention: Trail Making Test Part

optimal cut-off value.62,63 Optimal cut scores were also obtained for

A (limit 300 seconds), Number Span (forward and backward); (4) Lan-

reaching 80% sensitivity or specificity, depending on the application

guage: Multilingual Naming Test (MINT, total score), Category Fluency

of use. For purposes of conversion from the T-MoCA to the MoCA-

(Animals, Vegetables: 1 minute each); (5) Visual-spatial: Benson Imme-

30, two methods were used. The first method was equipercentile

diate Recall, WAIS III Block Design. The following actuarial formula was

equating with log-linear smoothing, which mapped the T-MoCA and

used: (1) impaired scores, defined as >1 SD below the age, gender, and

MoCA-30 based on their percentile ranks. In the second method, a

education adjusted normative mean, on both measures within at least

Poisson regression model for MoCA-30 was applied using T-MoCA

one cognitive domain (i.e., memory, language, or speed/executive func-

and covariates that may influence the estimate.

tion); or (2) one impaired score, defined as >1 SD below the age, gen-

The equipercentile equating analysis was conducted in R 4.0.164

der, and education adjusted normative mean, in each of three of the

using the “equate” package.65 All other analyses were performed using

five cognitive domains measured. If neither of these criteria was met,

SAS statistical software version 9.4 (SAS Institute, Inc.).

a score of 4, indicating the number of items of functional inability on
all four instrumental activities of daily activities items (IADL: Table S4
in supporting information) on the Lawton Brody scale53 must occur for

3

RESULTS

an individual to be classified as MCI. Otherwise, an individual was considered to be NC.

3.1

Overview

Baseline administration of the T-MoCA occurred within a mean of 22.7

2.5

Data analyses

(SD = 17.0) days of the in-person MoCA-30 administration. Participants’ age ranged from 70 to 94 (mean = 78.1, SD = 5.2) years, the

Baseline demographic and clinical characteristics were summarized by

sample was 66% female, and educational achievement averaged 14.9 ±

clinical cognitive status (MCI, NC) and compared using the Wilcoxon

3.5 years. The sample was 46% White, 37% Black, 14% Hispanic, and

rank sum tests for continuous variables, and Chi-square or Fisher’s

2% reported other or more than one race/ethnicity (Table 1). In total,

exact test for categorical variables. Pearson correlation was used to

149 participants were classified as MCI using Jak/ Bondi actuarial cri-

examine the association between the T-MoCA and MoCA-22. Where

teria. As shown in Table 1, those classified as MCI were significantly

appropriate, effect sizes are reported using Cohen’s d statistic.

older at baseline (mean 79.1, SD = 5.5. years vs. 77.6, SD = 5.0 years,

When making direct comparisons, the T-MoCA and MoCA-22 were

Cohen’s d = 0.30, P = 0.004), less educated (mean 14.3, SD = 3.6 years

examined because both instruments contained the same items. Lin-

vs. 15.3, SD = 3.4 years, Cohen’s d = 0.29, P = 0.02), and more

ear regression models were applied to evaluate associations of the T-

likely to be Black (for MCI, 34% White, 47% Black,16% Hispanic, 3%

MoCA, MoCA-22, and the difference scores (T-MoCA minus MoCA-

other/more than one race vs. for No MCI, 53% White, 32% Black, 13%

5 of 11
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TA B L E 1

Baseline descriptive characteristics of sample by MCI status
All

No MCI

MCI

Mean (SD) or percentage

N = 428

N = 279

N = 149

P*

Age (in years) at time of T-MoCA

78.1 (5.2)

77.6 (5.0)

79.1 (5.5)

0.004

Education, years

14.9 (3.5)

15.3 (3.4)

14.3 (3.6)

0.02

Gender, % Female

66%

66%

65%

0.80

% White non-Hispanic

46%

53%

34%

0.001

% Black

37%

32%

47%

Ethnicity:

% Hispanic

14%

13%

16%

% Others or more than one race

2%

1%

3%

GDS Score

2.3 (2.1)

2.1 (1.8)

2.8 (2.4)

0.004

MoCA-30 – Standard

23.3 (3.7)

24.6 (3.0)

20.7 (3.6)

<0.0001

MoCA-22

17.4 (2.8)

18.3 (2.3)

15.5 (2.7)

<0.0001

T-MoCA

17.3 (2.8)

18.0 (2.6)

16.0 (2.7)

<0.0001

Paired difference (T-MoCA minus MoCA-22)

−0.05 (2.6)

−0.3 (2.5)

0.5 (2.7)

0.002

Interval between telephone and in person administration (in days)

22.7 (17.0)

22.5 (17.0)

23.1 (17.1)

0.68

Subjective cognition self-report score (range 0–9)

2.9 (2.4)

2.6 (2.2)

3.5 (2.7)

<0.001

Telephone administration difficulties (range 0–1)

11%

8%

17%

0.005

Abbreviations: GDS, Geriatric Depression Scale; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; MoCA-22, MoCA subset; T-MoCA,
telephone MoCA.

Hispanic, and 1% other/more than one race, P = 0.01). Those with MCI

−0.04, SD = 2.56, 95% (confidence interval [CI]: −0.28 to 0.21) and

also had more cognitive concerns (mean 3.5, SD = 2.7 vs. 2.6, SD = 2.2,

the difference in scores was not related to any demographic factor,

Cohen’s d = 0.40, P < 0.001), more depressive symptoms (mean GDS

GDS, cognitive concerns, or telephone issues (Table 2). The differ-

2.8, SD = 2.4 vs. 2.1, SD = 1.8, Cohen’s d = 0.33, P = 0.004), and more

ence between the T-MoCA and the MoCA-22 was not significantly

concerns noted by telephone interviewers (17% vs. 8%, P = 0.005). The

different from zero (P = 0.76) using a paired t-test. The equivalence

groups did not differ by gender (% women 65% vs. 66%, P =0 .80). The

test concluded that the T-MoCA and the MoCA-22 were equivalent

Pearson correlation between the T-MoCA and the MoCA-22 was 0.58

(P < 0.0001). The equivalence between the two measures was also

(P < 0.0001); the correlation between the T-MoCA and MoCA-30 was

reflected in the 80% confidence interval of the difference (–0.24 to

0.56 (P < 0.0001).

0.17), which falls within the lower and upper equivalence bounds.
We used a Bland–Altman plot to examine the relationship of the
difference score between the MoCA-22 and T-MoCA and the aver-

3.2
Characteristics of the MoCA-22 and the
T-MoCA

age total score on both tests. The plot shows that when examining
the average scores of both test versions, there is no consistent pattern for the difference scores between tests with approximately equal

Scores on the MoCA-22 and T-MoCA were significantly associated

numbers of individuals with positive and negative differences (see

with education, race/ethnicity, depressive symptoms, and telephone

Figure 1).

administration difficulties. Age was significantly related to the MoCA22 only, and gender and self-reported cognitive concerns were significantly associated only with the T-MoCA, although the associations of
these factors with both modalities of the MoCA trended in the same

3.3
MCI

Discriminative ability of the instruments for

direction. Older age, Black or "All others" ethnicity (consisting of Hispanics and Others/more than one race), higher GDS scores, presence

ROC analysis was used to evaluate the diagnostic ability of the T-

of telephone administration difficulties, and greater cognitive concerns

MoCA, MoCA-22, and MoCA-30 for MCI (see Figure 2). The T-MoCA

were associated with worse MoCA performance on either instrument,

(AUC = 0.71) had a significantly lower AUC compared to the MoCA-22

while higher education and being a woman were associated with better

(AUC = 0.79; P = 0.002) and MoCA-30 (AUC = 0.80; P = 0.003), while

performance (Table 2).

the two in-person versions did not significantly differ from each other

The difference in scores between the T-MoCA and the MoCA-22

(P = 0.23). Comparisons of the various cut scores to classify MCI are

was also computed for each participant. The mean difference was

shown in Table 3, which summarizes the operating characteristics of
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TA B L E 2 ** Association of MoCA-22, T-MoCA, and the difference between the T-MoCA and MoCA-22 with demographics, depression,
subjective concerns, and issues related to telephone administration

MoCA-22

Difference between T-MoCA and
MoCA-22 (T-MoCA–MoCA22)

T-MoCA

Estimates

S.E.

P-value

Estimates

S.E.

P-value

Estimates

S.E.

P-value

Intercept

17.81

0.24

<.0001

17.55

0.24

<.0001

−0.26

0.24

0.28

Age*

−0.06

0.02

0.01

−0.03

0.02

0.16

0.03

0.02

0.25

Education*

0.20

0.04

<.0001

0.16

0.04

<.0001

−0.03

0.04

0.36

Gender

0.63

0.27

0.02

0.86

0.26

0.001

0.24

0.27

0.38

Black (ref. non-Hispanic White)

−1.39

0.29

<.0001

−1.23

0.28

<.0001

0.17

0.29

0.57

All others

−1.65

0.36

<.0001

−1.63

0.36

<.0001

0.02

0.37

0.95

Depression* (GDS)

−0.12

0.06

0.05

−0.20

0.06

0.002

−0.07

0.06

0.26

Sum of subjective concerns*

−0.07

0.05

0.17

−0.11

0.05

0.05

−0.03

0.06

0.57

Any telephone issues

−0.95

0.40

0.02

−0.82

0.40

0.04

0.13

0.41

0.76

*Age, education, GDS; sum of subjective cognitive concerns were all centered at overall mean.
**Based on n = 425 participants; three participants had missing values for sum of subjective concerns and were excluded.
Abbreviations: GDS, Geriatric Depression Scale; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; MoCA-22, MoCA subset; T-MoCA,
telephone MoCA.

F I G U R E 1 Bland–Altman plot for examining the relationship of the difference score between the Montreal Cognitive Assessment subset
(MoCA-22) and telephone MoCA (T-MoCA) and the average total score on both tests

the three MoCA measures using three different cut scores (Youden’s

a sensitivity of 72%, however, specificity was only 60%. When set-

index, sensitivity > = 80%, and specificity > = 80%). Youden’s index

ting sensitivity at > = 80%, the specificity of MoCA-30 was 57%, fol-

cut score, which optimizes sensitivity and specificity, showed that the

lowed by the MoCA-22 (52%) and T-MoCA (49%). Setting specificity

MoCA-30 was the most balanced, followed by the MoCA-22. At the

at > = 80%, the sensitivity of the MoCA-30 was 57%, compared to 50%

optimal cut point of 17 based on Youden’s Index, the T-MoCA had

for the MoCA - 22 and 41% for the T-MoCA.
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TA B L E 3

Sensitivity, specificity, positive predictive value, and negative predictive value for the MoCA-30, MoCA-22, and the T-MoCA*

MoCA-30

MoCA-22

T-MoCA

Cut score based on

Sensitivity

Specificity

Positive
predictive value

Negative
predictive value

Youden’s index cut = 22

0.70

0.77

0.63

0.83

Sensitivity > = 80% cut = 24

0.83

0.57

0.51

0.86

Specificity > = 80% cut = 21

0.57

0.85

0.66

0.79

Youden’s index cut = 17

0.79

0.67

0.56

0.86

Sensitivity > = 80% cut = 18

0.88

0.52

0.49

0.89

Specificity > = 80% cut = 15

0.50

0.88

0.69

0.77

Youden’s index cut = 17

0.72

0.59

0.49

0.80

Sensitivity > = 80% cut = 18

0.81

0.49

0.46

0.82

Specificity > = 80% cut = 15

0.41

0.83

0.56

0.72

*(< = cut as positive).
Abbreviations: MoCA, Montreal Cognitive Assessment; MoCA-22, MoCA subset; T-MoCA, telephone MoCA.

Sensitivity analyses were repeated on the subset (N = 288) who
completed the MoCA-30 and T-MoCA at their initial (baseline) study
visit. Results for the sensitivity analyses were similar to that within the
larger sample (Tables S5 and S6 in supporting information).

3.4
Conversion of scores from the T-MoCA to the
MoCA-30
Table 4 shows the results of the conversion from the T-MoCA to the
MoCA-30 using the equipercentile equating method. Using Poisson
regression, age, gender, race/ethnicity, and education were included
in the initial model and only education was significant when mapping
T-MoCA onto MoCA-30. Therefore, the final equation only included
education. The estimating equation for conversion for MoCA-30 is
exp(2.49 + 0.028*T-MoCA +0.011*education in years).

4

DISCUSSION

Remotely administered cognitive screening tools are increasingly used
in research and health-care settings.27 Such screens are often modified versions of standard in-person measures.29,67 Although widely
F I G U R E 2 Receiver operating characteristic (ROC) curves to
evaluate the diagnostic ability of the telephone Montreal Cognitive
Assessment (T-MoCA), MoCA subset (MoCA-22), and full MoCA
(MoCA-30) for mild cognitive impairment

used, the remote assessment versions are frequently validated in small,
select, homogenous samples; lack large-scale empirical support; and
direct comparisons between remotely administered and traditional inperson screens are rarely reported.29 To our knowledge, the current
study is the first to directly examine correspondence of the T-MoCA17
with the widely used in-person MoCA-304 and to determine conver-

To analyze the characteristics of individuals whose MCI classifi-

sion scores in a well-characterized, demographically diverse cohort

cation disagreed between the T-MoCA and the MoCA-22, we used

of older adults. Results indicate that the T-MoCA is equivalent to

Youden’s index cut score for assessment and examined the effect of

the MoCA-22, and to the corresponding in-person MoCA-30. Con-

age, education, gender, race/ethnicity, and telephone difficulties. Diag-

sistent with previous work,17–19 our findings support that the diag-

nostic discrepancies occurred in the 114 individuals. None of the

nostic accuracy of T-MoCA to detect MCI is 0.72, which is slightly

covariates was significantly associated with the probability of having

diminished compared to in-person administration modalities. Never-

different diagnoses.

theless, our study indicates that the T-MoCA is a valuable cognitive
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TA B L E 4 Conversion from T-MoCA to MoCA-30 score using the
equipercentile method
T-MoCA

Converted MoCA-30

person can no longer attend in-person visits due to health problems;
have moved; or as we have seen recently, have safety concerns related
to a pandemic. Using the conversion scores derived from the log-linear
smoothing method presented in Table 4, participant scores on the T-

0

0

1

0

2

1

3

3

4

4

tion affords the opportunity to take account of these factors (e.g., in the

5

6

current study, education was a significant covariate, which is therefore

6

8

included in the Poisson equation).

7

9

The optimal cut score for discriminating between those classified

8

11

as MCI versus those with normal cognition depends upon the clini-

9

12

10

14

11

15

12

16

MoCA-22 perform the best using this index; however, the T-MoCA is

13

18

adequate. The current investigation also provides cut scores to achieve

14

19

at least 80% sensitivity or 80% specificity. If the objective is to use

15

20

telephone-administered screens to identify individuals who may have

16

22

MCI for a low-cost, low-risk intervention, a cut score that emphasizes

17

23

sensitivity may be optimal. In addition, if a positive telephone screen

18

24

19

25

20

27

21

28

fer. However, if the goal is to identify candidates for a costly or inva-

22

30

sive next step, such as positron emission tomography scanning or lum-

Abbreviations: MoCA, Montreal Cognitive Assessment; T-MoCA, telephone MoCA.

MoCA can be expressed in the terms of the MoCA-30. This is especially useful for clinicians when in-person assessments are not feasible.
In addition, in research settings when harmonization across studies is
necessary, relevant covariates should be considered. The Poisson equa-

cal, research, or public health context. The optimal rule is based on
Youden’s index, which selects the cut score that maximizes the sum of
sensitivity and specificity, maximizing the number of correctly classified individuals. This index indicates that the in-person MoCA-30 and

is to be followed by a safe and more specific test for definitive diagnosis, sensitivity may be more important than specificity, to maximize
identification of individuals with MCI. Setting sensitivity to be at least
80%, our results show that the specificity of the three instruments suf-

bar puncture, it may be desirable to maximize specificity of remotely
administered screeners to minimize follow-up screening in individuals falsely classified as MCI. When specificity is specified to be greater
than or equal to 80%, our results show that the sensitivity of the MoCA-

screen that can be used to detect MCI when in-clinic assessment is not

30, the MoCA-22, and the T-MoCA are reduced. Just as the MoCA-30

available.

or the MoCA-22, the T-MoCA can deliver high specificity or high sensi-

Often appealing and efficient for health-care professionals and

tivity but the trade-offs are large. For this reason, the clinician or inves-

researchers, remotely administered assessment tools like the T-MoCA

tigator using the T-MoCA must select the cut scores optimized for their

are also well accepted by older adult patients and study participants.

purpose.

For example, telephone-administered measures are cost-effective,

In a screening context in which sensitivity matters, the T-MoCA

allow for quick and flexible screening, overcome geographical barri-

could be used to identify individuals who warrant further evaluation.

ers, and lower dropout rates in longitudinal aging studies.68–70 For

MCI is difficult to target because diagnosis is assigned based on

older adults, especially those with reduced mobility and/or med-

thresholds of cognitive performance on tests with imperfect retest

ical comorbidities, remotely implemented screens are convenient

reliabilities. In addition, back conversion from MCI to cognitive normal-

tolerated.29

Recent years have seen the emergence of

ity ranges from 16% to 39% of diagnosed cases in community-based

videoconference-based cognitive screens conducted via computer,

studies.71–73 Therefore, disagreements between the MoCA in its

smartphone, or tablet, yet they rely on costly equipment and techno-

various forms and MCI status reflects, at least in part, the fallibility of

logical knowledge for administration, which greatly limits their broad

MCI as the gold standard. There are several approaches to extending

applicability. Telephone-based screens can facilitate continuity of care,

this work. One approach would be to use more robust definitions

monitoring of disease progression, and clinical and research follow-up

of MCI, based on follow-up data or biomarkers. Another approach

when in-person visits are not feasible.

might be to assess the relationship of MoCA performance to the

and well

An important application of the current study is to facilitate the

distal outcomes of primary interest. A third approach would be to

transition from the standard MoCA-30 to the T-MoCA and vice versa.

assess change in T-MoCA performance as a predictor of distal MCI

This is critical for when patients or study participants initially seen in

outcomes.
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Participant age, education level, gender, race/ethnicity, level of sub-

original MoCA-30 and the MoCA-22 forms, is more sensitive for detec-

jective cognitive concerns, and/or telephone interviewer administra-

tion of MCI. Importantly, both the T-MoCA and the MoCA-30 should

tion concerns did not result in a difference in performance between

be viewed as screening rather than diagnostic measures. Patients pos-

MoCA administration modalities. Therefore, our findings suggest that

itively screening for MCI according to these tools should undergo fur-

while these relevant individual characteristics may influence perfor-

ther cognitive testing before a clinical diagnosis is assigned. Another

mance on the MoCA in general,33–39,41,42 these same variables do not

limitation is that formal hearing assessments were not performed.

influence differential performance between MoCA versions adminis-

Instead, documentation of hearing difficulties was based on observa-

tered in-office or remotely. This finding is consistent with previous

tions and assessments of research assistants. Thus, our findings under-

work examining a videoconference-based MoCA version.20 Confound-

score the necessity of in-person assessment when possible, with the

ing by demographic variables is not likely to differentially impact the

gold standard being comprehensive neuropsychological assessment of

administration mode and our study suggests that scores on the T-

cognition.

MoCA reflect in-person administration. It is also important to note that

Telephone screens of cognition are a convenient complement to

any concerns noted by the telephone screener (see Table S3), includ-

clinical care and research, as they are efficient, inexpensive, and

ing problems with hearing, diminished attention or motivation, unau-

unaffected by traditional barriers to services, including geographic

thorized use of external sources, and/or anxiety about performance did

and socioeconomic factors. Beyond their broad accessibility, remotely

not affect performance on the T-MoCA compared to the in-clinic ver-

administered tools like the T-MoCA, have been proven crucial to facil-

sion. This is an important finding, as it demonstrates that possible con-

itate continuity of care, disease monitoring, and follow-up when in-

founding variables related to telephone administration do not mean-

person assessment is not feasible. The current study provides support

ingfully impact performance.

that the T-MoCA is equivalent to in-person administered modalities.

The current study demonstrates several notable strengths. First,

Further, we provide two methods to facilitate conversion between T-

despite growing demand for validated telephone cognitive measures,

MoCA and original MoCA-30, which will simplify long-term follow-up

there is a dearth of literature specifically examining the T-MoCA,

assessments of cognition in clinical settings and facilitate harmoniza-

which is the telephone version of one of the most widely used cogni-

tion of cognitive data among multicenter longitudinal cohort studies.

tive screens.4 We identified only three articles characterizing the TMoCA,17–19 including the initial development and validation study.17
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